Prosensa and GlaxoSmithKline expand Duchenne dystrophy alliance

24.06.2010

Leiden - Prosensa NV and British drugmaker GlaxoSmithKline have expanded their cooperation concerning RNA-modulating drugs against Duchenne muscular dystrophy (DMD). Two programmes, covering 4 drug new drug candidates for specific patient subpopulations, have been added to the existing collaboration in DMD. According to the terms of the agreement, GSK has paid two upfront fees and will add milestones dependant on research progress. Within the new programmes, Prosensa and GSK will focus on the skipping of four exons (exon 45, 52, 53, and 55), in addition to their existing programmes that target skipping of exon 51 and 44 (PRO051/GSK2402968 and PRO044). GSK has an option to select two of these additional four compounds for later-stage development and commercialization. Prosensa will retain certain limited European commercialisation rights alongside GSK for the two compounds selected by GSK. For the two compounds not selected by GSK, Prosensa will retain full commercialization rights.

Paris/Gosselies – Biotech cluster Lyonbiopôle in the Rhône-Alpes region and Biowin, which is based in the French-speaking part of Belgium, have laid the foundations for a transborder cluster. “From the outset, we wanted to adopt...

Ghent – BASF Plant Science and the Flanders Institute for Biotechnology (VIB) have signed a major cooperation agreement on research into plant genetic mechanisms to increase yield and improve tolerance to environmental stress...

Brussels – The 21 research groups and five SMEs that make up the new EU-funded LipidomicNet project have launched a knowledge platform on Wikipedia (www.lipidomicnet.org). The novel resource, which will be regularly updated by...

Luxembourg – The government of Luxembourg has tapped three prominent US biomedical science organisations to accelerate the country’s pace of innovation in the biosciences by developing a biobank, to conduct two major projects to...

Ghent – Belgian researchers under Freddy Haesebrouck have for the first time cultured the animal pathogen Helicobacter suis, which causes deadly stomach ulcers in pigs. Because the new species is related to the human pathogen...

Professor Erik De Clercq (University of Leuven, Belgium) has received the European Inventor of the Year 2008 award. De
Clercq pioneered the use of nucleotide analogues to treat viral infections causing herpes, hepatitis B and...

Amsterdam – In order to enhance the valorisation of academic results, the Netherlands Genomics Initiative (NGI) is now supporting the foundation of new companies. Teams of researchers and entrepreneurs from all of the NGI’s...

Ghent – Pronota NV, a biomarker specialist firm that is based in Belgium, has launched its protein biomarker verification platform MASSterclass™. Pronota says that the novel antibody-free system will help to reduce the cost and...

Partner-Events

Stockholm (SE)

Wien (A)

Product of the week

BioShake Series

The BioShake series contains high-speed mixer and thermal mixer for small and very small volumes in microplates and reaction tubes and allows for the first time high precise and efficient mixing in the microliter scale for a wide range of applications. more